Cargando…
Inhibiting the HPV16 oncogene-mediated glycolysis sensitizes human cervical carcinoma cells to 5-fluorouracil
BACKGROUND: Human papillomavirus (HPV), the major cause of cervical cancer worldwide, is associated with infection of HPV (Oncogenic HPV). Cancer patients who develop drug resistance are resulted in failure of chemotherapy. OBJECTIVE: We investigated the mechanisms for the HPV E6/E7 oncoprotein-medi...
Autores principales: | Ma, Dan, Huang, Yong, Song, Shurong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707439/ https://www.ncbi.nlm.nih.gov/pubmed/31695407 http://dx.doi.org/10.2147/OTT.S205334 |
Ejemplares similares
-
hnRNP E1 Regulates HPV16 Oncogene Expression and Inhibits Cervical Cancerization
por: Song, Li, et al.
Publicado: (2022) -
RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma
por: Yu, Qianqian, et al.
Publicado: (2018) -
Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits
por: Radaelli, Antonia, et al.
Publicado: (2010) -
Terc is dispensable for most of the short-term HPV16 oncogene-mediated phenotypes in mice
por: Achilleos, Charis, et al.
Publicado: (2018) -
Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression
por: Liu, Hang, et al.
Publicado: (2022)